Cargando…
Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer
Malignant pericarditis, when associated with massive pericardial effusion, presents a critical condition in lung cancer patients. Because this condition often arises in terminally ill patients, intensive therapy such as multi-drug combination chemotherapy is rarely appropriate. This study evaluated...
Autores principales: | Moriya, T, Takiguchi, Y, Tabeta, H, Watanabe, R, Kimura, H, Nagao, K, Kuriyama, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374680/ https://www.ncbi.nlm.nih.gov/pubmed/10970685 http://dx.doi.org/10.1054/bjoc.2000.1397 |
Ejemplares similares
-
Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021) -
Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study
por: Kotake, Mie, et al.
Publicado: (2019) -
Voluminous Intrapericardial Lipoma Mimicking Pericardial Effusion
por: Prado de Morais, Fabíola, et al.
Publicado: (2020) -
A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009) -
Unusual intrapericardial pressure pattern in localized pericardial effusion
por: Yalonetsky, Sergey, et al.
Publicado: (2020)